The Patent Finder

Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers

Quiapeg Pharmaceuticals AB

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 61/658,827, filed Jun 12, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,220,789Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
In force
 · High confidence
UsedRemaining
Quiapeg Pharmaceuticals ABIn forceHigh confidence
US 10,207,007Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
In force
 · High confidence
Quiapeg Pharmaceuticals ABIn forceHigh confidence
US 10,653,788Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
In force
 · High confidence
Quiapeg Pharmaceuticals ABIn forceHigh confidence
US 11,723,981Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
In force
 · High confidence
Quiapeg Pharmaceuticals ABIn forceHigh confidence
US 10,973,921Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
Lapsed Apr 13, 2025 on the fee record
High confidence
Quiapeg Pharmaceuticals ABLapsed Apr 13, 2025 on the fee recordHigh confidence
US 9,849,187Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
Lapsed Dec 26, 2025 on the fee record
High confidence
Quiapeg Pharmaceuticals ABLapsed Dec 26, 2025 on the fee recordHigh confidence
US 11,382,984Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
Lapsed Jul 12, 2026 on the fee record
High confidence
Quiapeg Pharmaceuticals ABLapsed Jul 12, 2026 on the fee recordHigh confidence
Application 18/202,880Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers
Abandoned
Abandoned Feb 26, 2026
Quiapeg Pharmaceuticals ABAbandonedAbandoned Feb 26, 2026
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Quiapeg Pharmaceuticals AB.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited